Israeli bio-pharmaceutical company Kamada announced that it has obtained FDA approval to conduct a clinical trial in the US for the company’s next generation drug for the treatment of cystic fibrosis. The drug is an inhalable version of company’s AAT drug (Alpha-1 Antitrypsin deficiency). The current FDA approval is partly based on successful pre-clinical trials of the […]

Drug development company BiolineRX announced that it has received approval from Israel’s Ministry of Health to commence a Phase II trial of its treatment for inflammatory bowel disease (IBD). The company reported that the Phase II trial will be an open-label study to evaluate the efficacy, safety and tolerability of the treatment, BL-7040, in up […]

Teva Pharmaceutical Industries reported positive results from Phase III clinical studies for its QNASL nasal spray. The spray is designed to treat seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). The trials tested the efficacy and safety of the spray, as well as the impact on quality of life. The results were reported at […]

Israeli company Gamida Cell will raise $10 million in an internal round from its shareholders, including an owners’ loan of $4 million. Elbit Medical Technologies, which owns 31.6% of Gamida Cell, will invest $3 million in the round. Gamida Cell develops stem cell therapy products for transplantation and regenerative medicine. It is soon to start a […]

Prolor Biotech Inc. reported positive results in a study of its new version of the hemophilia drug Factor VIIa-CTP in a pre-clinical trial on mice. The study showed that mice which received the longer-acting version of the drug showed a higher survival and recovery rate over a longer period of time, compared to those that […]

Israeli researchers have discovered a protein that seems to prevent the growth of pancreatic cancer. The protein could potentially be effective against other aggressive cancers as well.